KIR5.1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-80079
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the middle region of human KCNJ16. Peptide sequence RESCTSDTKARRRSFSAVAIVSSCENPEETTTSATHEYRETPYQKALLTL. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for KIR5.1 Antibody
Western Blot: KIR5.1 Antibody [NBP1-80079]
Western Blot: KIR5.1 Antibody [NBP1-80079] - Titration: 0.2-1 ug/ml, Positive Control: 721_B cell lysate.Applications for KIR5.1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KIR5.1
Alternate Names
BIR9, Inward rectifier K(+) channel Kir5.1, inward rectifier K+ channel KIR5.1, inward rectifier potassium channel 16, KIR5.1, MGC33717, Potassium channel, inwardly rectifying subfamily J member 16, potassium inwardly-rectifying channel, subfamily J, member 16
Gene Symbol
KCNJ16
UniProt
Additional KIR5.1 Products
Product Documents for KIR5.1 Antibody
Product Specific Notices for KIR5.1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...